Free Classifieds at USNetAds.com - View Item Content by ID 131515760

USNetAds > Health & Beauty > Other Health Ads > Item ID 131515760

Item ID 131515760 in Category: Health & Beauty - Other Health Ads

Cannot view this item. It could be pending, expired or deleted.
Below item is randomly selected from the same category and may have similar content.

Explore Groundbreaking Research on PRRT Toxicity and Survival


Free Online Advertising
Free Internet Web Site Advertising.


UK Free Classifieds
United Kingdom Free Ads Website.
100% Free Ad Posting.


Canada Free Ads
Popular Online Classifieds in Canada.
No Sign up, No Email Required to Post.

Are you or a loved one navigating treatment options for metastatic neuroendocrine tumors (NETs)? A new study sheds light on the safety and efficacy of Peptide Receptor Radionuclide Therapy (PRRT), comparing two agents—177Lu-DOTATATE and 90Y-DOTATOC—to optimize patient care and outcomes.
Key Insights You'll Discover:
• Minimal Renal Toxicity: Stable renal function observed with both PRRT agents.
• Hematological Effects: 177Lu-DOTATATE linked to minor blood cell and platelet reductions.
• Progression-Free Survival (PFS): 177Lu-DOTATATE improves PFS significantly compared to 90Y-DOTATOC.
• Overall Survival (OS): No significant OS difference between the treatments.
• Monitoring Needs: Regular blood health assessments are crucial during PRRT.
Why It Matters:
This cutting-edge research highlights how PRRT can extend disease progression while maintaining safety, empowering patients and providers to make informed treatment decisions.
Learn More About:
• The differences in efficacy between 177Lu-DOTATATE and 90Y-DOTATOC.
• How personalized care can improve quality of life for NET patients.
• The importance of monitoring and managing side effects for better outcomes.
Visit Our Website to read the full study and gain valuable insights into this life-changing therapy.
https://mdnewsline.com/comparing-prrt-agents-in-neuroendocrine-tumors-toxicity-and-survival/


Related Link: Click here to visit item owner's website (0 hit)

Target State: All States
Target City : All Cities
Last Update : Dec 23, 2024 6:36 AM
Number of Views: 40
Item  Owner  : MDNewsline
Contact Email:
Contact Phone: (None)

Friendly reminder: Click here to read some tips.
USNetAds > Health & Beauty > Other Health Ads > Item ID 131515760
 © 2024 USNetAds.com
2024-12-25 (0.579 sec)